Malaria: all 1,315 studies
Page 12 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Phase II Artesunate Study in Severe MalariaCompletedNCT00522132Phase 2
- Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum MalariaCompletedNCT00519467Phase 2
- Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in TanzaniaCompletedNCT00513669Phase 1
- Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria VaccineCompletedNCT00509158Phase 1/2
- Malaria Incidence in Infants in Bancoumana, MaliCompletedNCT00508417
- The Effect of Malaria on Disease Progression of HIV/AIDSCompletedNCT00499876Not applicable
- RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian InfantsTerminatedNCT00497471Not applicable
- Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During PregnancyCompletedNCT00495508Phase 4
- Trial of Rapid Diagnostic Tests in Rural GhanaCompletedNCT00493922Phase 4
- Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western CambodiaCompletedNCT00493363Not applicable
- Safe Pregnancy by Infectious Disease ControlCompletedNCT00489619
- Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium FalciparumCompletedNCT00487916Phase 1
- Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax MalariaCompletedNCT00486694Phase 2
- Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum MalariaCompletedNCT00484900Phase 3
- Artemisinin Resistance in CambodiaCompletedNCT00479206Not applicable
- Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT00471666
- Normal Immunological Parameters Among Healthy Volunteers in Kambila, MaliCompletedNCT00471302
- Phase Ib Trial of MSP3 LSP in Children in TanzaniaStatus unknownNCT00469651Phase 1
- Plasmodium Resistance in A. GambiaeCompletedNCT00466557
- Improved Management and in-Hospital MortalityCompletedNCT00465777Not applicable
- Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in ZanzibarSuspendedNCT00465257Phase 4
- Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan ChildrenCompletedNCT00461578Not applicable
- Treatment of Uncomplicated Malaria in BeninCompletedNCT00460369Not applicable
- Food-Effect Bioavailability Study of AQ-13, a Candidate AntimalarialCompletedNCT00455494Phase 1
- Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in TanzaniaCompletedNCT00454961Phase 4
- Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese ChildrenTerminatedNCT00453856Phase 4
- ACT MALI: Treatment of Malaria Based on Combination TherapiesCompletedNCT00452907Phase 4
- A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina FasoStatus unknownNCT00452088Phase 1
- Evaluation of Rapid Diagnosis Tests in Imported MalariaCompletedNCT00451269
- Ototoxicity of Artemether / Lumefantrine (Coartem) and Other AntimalarialsCompletedNCT00451139Phase 4
- Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceCompletedNCT00445796Phase 4
- Characterisation of the Immune Responses of 2 Experimental Malaria VaccinesCompletedNCT00443131Phase 2
- Clinical Evaluation of Mosquito Coils to Control Malaria in ChinaStatus unknownNCT00442442Phase 3
- Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum MalariaSuspendedNCT00442403Phase 3
- Study to Investigate the Induction of an Protective Immune Response to MalariaCompletedNCT00442377Not applicable
- Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in PregnancyCompletedNCT00432367Phase 3
- Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])Status unknownNCT00431808Phase 1
- Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria VaccineCompletedNCT00427167Phase 1
- Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea BissauCompletedNCT00426439Phase 4
- Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum MalariaCompletedNCT00425763Phase 4
- Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria VaccineStatus unknownNCT00424944Phase 1
- Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected PatientsCompletedNCT00421473Phase 4
- Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of TreatmentCompletedNCT00414479
- Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for MalariaCompletedNCT00414336Phase 1
- Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost RegimenCompletedNCT00408668Phase 1/2
- Prophylactic Antimalarial Activity of DB289 in VolunteersCompletedNCT00408369Phase 1/2
- Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian ChildrenStatus unknownNCT00406146Phase 3
- Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated PeptidesTerminatedNCT00400101Phase 1
- Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell AnemiaCompletedNCT00399074Phase 3
- GMZ2-Aluminum Hydroxide Phase I, TübingenStatus unknownNCT00397449Phase 1
- Malaria Transmission and Immunity in Highland KenyaCompletedNCT00393757
- Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African ChildrenCompletedNCT00393679Phase 3
- Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.CompletedNCT00386763Phase 3
- Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory FunctionTerminatedNCT00386750Phase 4
- Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted ConditionsCompletedNCT00386503Phase 1
- A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in AdultsCompletedNCT00385047Phase 1/2
- Congenital and Neonatal Malaria in MaliCompletedNCT00384267
- Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant WomenCompletedNCT00380146Not applicable
- Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in ColombiaCompletedNCT00378625Phase 3
- CS DNA MVA Trial in Mampong, GhanaWithdrawnNCT00377494Phase 1
- Comparison of Two Strategies for the Delivery of IPTcCompletedNCT00376155Phase 4
- Sporozoite Challenge of Polyprotein VaccineesCompletedNCT00375128Phase 1/2
- Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PPCompletedNCT00374998Phase 1
- Randomized Trial on Effectiveness of ACTs in GhanaTerminatedNCT00374205Phase 4
- Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in PeruCompletedNCT00373607Phase 3
- PALUREA: Severe Imported Malaria in AdultsCompletedNCT00372684
- IPT of Malaria With SP in Different Zones of Drug Resistance in RwandaCompletedNCT00372632Phase 4
- Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated MalariaCompletedNCT00371735Phase 3
- Adenovirus Vaccine for MalariaCompletedNCT00371189Phase 1
- Study of Factors Involved in Resistance to Severe MalariaCompletedNCT00368810
- Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.CompletedNCT00367653Phase 3
- RBx11160 Phase II Dose Ranging Study RBx/MMV05-06CompletedNCT00362050Phase 2
- IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.TerminatedNCT00361114Phase 3
- Relationship Between HIV and Malaria in Ugandan ChildrenCompletedNCT00356824
- Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in BangladeshCompletedNCT00356005Phase 2
- Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina FasoCompletedNCT00355225Not applicable
- Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot StudyCompletedNCT00354380Phase 2
- The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed CommunitiesCompletedNCT00351013Phase 4
- Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered IntramuscularlyCompletedNCT00347555Phase 1
- Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaCompletedNCT00347113Not applicable
- Analysis of the Immune Response to the Malaria Parasite in Mali, West AfricaCompletedNCT00346346
- AMA1-C1/Alhydrogel + CpG 7909 for MalariaCompletedNCT00344539Phase 1
- Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated MalariaCompletedNCT00344006Phase 3
- Experimental Vaccine for Malaria in Adults in MaliCompletedNCT00343005Phase 1
- Examination of Protective Factors Against Severe MalariaCompletedNCT00342043
- Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, MaliTerminatedNCT00341783
- Malaria Vaccine in Children in MaliCompletedNCT00341250Phase 1/2
- Severe Malaria and Anti-malarial Drug Resistance in CambodiaCompletedNCT00341003
- Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)CompletedNCT00340574Phase 1
- Experimental Vaccine for Plasmodium Falciparum MalariaCompletedNCT00340431Phase 1
- Hyperphenylalaninemia in Cerebral MalariaCompletedNCT00338520
- Use of Rapid Diagnostic Tests for Malaria Case Management in KenyaCompletedNCT00336388Not applicable
- Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and GenotypingCompletedNCT00336375Phase 4
- Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With MalariaTerminatedNCT00331708Not applicable
- Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in SudanCompletedNCT00330902Phase 3
- Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum MalariaCompletedNCT00329134Phase 2
- Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, UgandaCompletedNCT00327964
- Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With ChloroquineCompletedNCT00323375Phase 1
- Cotrifazid Safety and Efficacy Against MalariaTerminatedNCT00322907Phase 2
- Malaria Prevalence in ChildrenCompletedNCT00322816